Effect of Alcoholic Extract of the Olive Leaf on Clinical and Laboratory Outcomes of Patients with COVID-19: A Study Protocol

Ahmadpour, Elham; Yarahmadi, Sajad; Toulabi, Tahereh

doi:10.22087/ijac.2024.469830.1016

Effect of Alcoholic Extract of the Olive Leaf on Clinical and Laboratory Outcomes of Patients with COVID-19: A Study Protocol

Document Type : Protocol Study

Authors

Elham Ahmadpour ¹

Sajad Yarahmadi ²

Tahereh Toulabi ³

¹ Student Research Committee, School of Nursing and Midwifery, Lorestan University of Medical Sciences, Khorramabad, Iran

² Lorestan university medical sciences, Khorramabad, Iran

³ Lorestan university of medical sciences

10.22087/ijac.2024.469830.1016

Abstract

The COVID-19 pandemic is rapidly spreading on a global scale, posing significant challenges to the efficacy of healthcare systems in developed nations. The clinical manifestations of COVID-19 are varied and nonspecific, encompassing a spectrum from mild to severe respiratory, constitutional, and gastrointestinal symptoms, potentially advancing to severe acute respiratory infection and acute respiratory distress syndrome. In light of the absence of approved effective treatments and the ongoing public health crisis, it is imperative to investigate the efficacy of existing antiviral and herbal medications against COVID-19. Research suggests that further investigation is warranted into the effectiveness of medicinal plants from India, China, and Iran in treating COVID-19. Phytomedicine involves the use of roots, seeds, leaves, bark, and flowers for therapeutic purposes, with some plants demonstrating antiviral properties. Studies have shown that over 75% of drugs used to treat viral diseases are derived from botanical sources. Among these herbal medicines, olives are noteworthy.

Keywords

Covid-19

Olive leaf extract

Clinical outcome

Complementary medicine

1. Agrawal M, Saraf S, Saraf S, Murty US, Kurundkar SB, Roy D, et al. In-line treatments and clinical initiatives to fight against COVID-19 outbreak. Respiratory medicine. 2020:106192.
2. Vahedi A, Tabasi F, Monjazebi F, Hashemian SMR, Tabarsi P, Farzanegan B, et al. Clinical Features and Outcomes of ICU Patients with COVID-19 Infection in Tehran, Iran: a Single-Centered Retrospective Cohort Study. TANAFFOS (Respiration). 2020;19(4):300-11.
3. Huang F, Li Y, Leung EL-H, Liu X, Liu K, Wang Q, et al. A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19). Pharmacological research. 2020:104929.
4. Porembskaya O, Lobastov K, Pashovkina O, Tsaplin S, Schastlivtsev I, Zhuravlev S, et al. Thrombosis of pulmonary vasculature despite anticoagulation and thrombolysis: The findings from seven autopsies. Thrombosis Update. 2020;1:100017.
5. Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complementary Therapies in Clinical Practice. 2020:101214.
6. Chatfield K, Salehi B, Sharifi-Rad J, Afshar L. Applying an ethical framework to herbal medicine. Evidence-Based Complementary and Alternative Medicine. 2018;2018.
7. Hung P-Y, Ho B-C, Lee S-Y, Chang S-Y, Kao C-L, Lee S-S, et al. Houttuynia cordata targets the beginning stage of herpes simplex virus infection. PLoS One. 2015;10(2):e0115475.
8. Moradi M-T, Rafieian-Kopaei M, Karimi A. A review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virus. Avicenna journal of phytomedicine. 2016;6(5):506.
9. Toulabi T, Delfan B, Rashidipour M, Yarahmadi S, Ravanshad F, Javanbakht A, et al. The efficacy of olive leaf extract on healing herpes simplex virus labialis: A randomized double-blind study. EXPLORE. 2021.
10. Şahin S, Samli R, Tan ASB, Barba FJ, Chemat F, Cravotto G, et al. Solvent-free microwave-assisted extraction of polyphenols from olive tree leaves: Antioxidant and antimicrobial properties. Molecules. 2017;22(7):1056.
11. Dunne EF, Friedman A, Datta SD, Markowitz LE, Workowski KA. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines. Clinical infectious diseases. 2011;53(suppl_3):S143-S52.